Table 1.
Baseline characteristics of coronavirus disease 2019 (COVID-19) patients with or without history of cerebrovascular disease (CVD).
| History of CVD n = 109 | No History of CVD n = 2,445 | P-Value | |
|---|---|---|---|
| Gender (Female) (proportion) | 61 (56.0) | 1,231 (50.3) | 0.251 |
| Age (year), median (IQR) | 71.0 (15.0) | 59.0 (18.0) | <0.001 |
| smoking (proportion) | 12 (11.0) | 185 (7.6) | 0.187 |
| Comorbidities (proportion) | |||
| Hypertension | 81 (74.3) | 713 (29.2) | <0.001 |
| Diabetes | 35 (32.1) | 355 (14.5) | <0.001 |
| Coronary heart disease | 27 (24.8) | 156 (6.4) | <0.001 |
| Atrial fibrillation | 1 (0.9) | 32 (1.3) | 1.000 |
| COPD | 5 (4.6) | 20 (0.8) | 0.001 |
| Chronic liver diseases | 8 (7.3) | 142 (5.8) | 0.506 |
| Chronic kidney diseases | 6 (5.5) | 59 (2.4) | 0.090 |
| Malignant tumors | 2 (1.8) | 52 (2.1) | 1.000 |
| Hematological diseases | 1 (0.9) | 32 (1.3) | 1.000 |
Data are described as median (IQR) or proportion (%); χ2 test or T-test was used to calculate P-value when appropriate. IOR indicates interquartile range; COPD indicates chronic obstructive pulmonary disease.